Accessibility Menu
 
Drägerwerk Ag & KGaA logo

Drägerwerk Ag & KGaA

(ETR) DRW8

Current Price$72.00
Market Cap$1.38B
Since IPO (2010)+103%
5 Year+13%
1 Year+37%
1 Month-2%

Drägerwerk Ag & KGaA Financials at a Glance

Market Cap

$1.38B

Revenue (TTM)

$3.48B

Net Income (TTM)

$139.50M

EPS (TTM)

$7.44

P/E Ratio

9.89

Dividend

$1.97

Beta (Volatility)

0.04 (Low)

Price

$72.00

Volume

1,533

Open

$73.00

Previous Close

$72.00

Daily Range

$71.40 - $73.20

52-Week Range

$46.50 - $76.00

DRW8 News

No articles available.

DRW8: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Drägerwerk Ag & KGaA

Industry

Healthcare Equipment and Supplies

Employees

16,687

CEO

Stefan Dräger

Headquarters

Lübeck, 23558, DE

DRW8 Financials

Key Financial Metrics (TTM)

Gross Margin

45%

Operating Margin

7%

Net Income Margin

4%

Return on Equity

9%

Return on Capital

10%

Return on Assets

4%

Earnings Yield

10.11%

Dividend Yield

0.03%

Payout Ratio

26.86%

Stock Overview

Market Cap

$1.38B

Shares Outstanding

18.72M

Volume

1.53K

Short Interest

0.00%

Avg. Volume

4.60K

Financials (TTM)

Gross Profit

$1.52B

Operating Income

$238.28M

EBITDA

$384.83M

Operating Cash Flow

$238.33M

Capital Expenditure

$71.82M

Free Cash Flow

$166.50M

Cash & ST Invst.

$284.06M

Total Debt

$405.11M

Drägerwerk Ag & KGaA Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.14B

+5.8%

Gross Profit

$517.67M

+4.8%

Gross Margin

45.47%

N/A

Market Cap

$1.38B

N/A

Market Cap/Employee

$89.20K

N/A

Employees

15,444

N/A

Net Income

$94.65M

+24.5%

EBITDA

$189.31M

+10.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$121.05M

+17.9%

Accounts Receivable

$947.28M

+10.4%

Inventory

$636.07M

-2.8%

Long Term Debt

$293.37M

+2.2%

Short Term Debt

$111.73M

+2.8%

Return on Assets

4.26%

N/A

Return on Invested Capital

9.71%

N/A

Free Cash Flow

$118.07M

+37.5%

Operating Cash Flow

$145.68M

+32.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NVV1.FNovavax, Inc.
$7.80-3.94%
NXU.DENexus AG
$71.20-0.14%
2B4.FBonesupport Holding AB (publ)
$17.39+4.13%
EUZ.DEEckert & Ziegler Strahlen- und Medizintechnik AG
$15.07+6.35%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$171.24-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$41.23-0.07%
EEIQEpicQuest Education Group International
$8.44+2.09%
MARAMara Holdings
$8.58+0.04%

Questions About DRW8

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.